Overview
Medtronic Diabetes is the world leader in insulin pump therapy and continuous glucose monitoring. Our first insulin pump, the Model 502, was introduced in July of 1983, and through continuous advancements in the technology and our products, the MiniMed Paradigm Pump is the #1 prescribed pump today.
Today, hundreds of thousands of people enjoy the benefits of our insulin pumps. Our Company is firmly committed to helping people living with diabetes live healthier and more normal lives by providing superior technology and responsive customer support.
Medtronic Diabetes takes great effort in setting the industry standard for customer service, advanced technology and educational programs, and is committed to creating greater awareness of insulin pump therapy and continuous glucose monitoring for the treatment of diabetes.
Medtronic Diabetes's vision is to eliminate the burdens associated with diabetes by creating an artificial pancreas. Along that path, we continue to develop advanced insulin pumps and continuous glucose monitoring systems for the treatment of diabetes. One day, these integrated systems will "close the loop" by making glucose sensing and insulin delivery automatic. Indeed, these are very exciting times for the Company, as we continue to make major advancements toward a vision that began over 25 years ago!